Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Frentzen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Genetics|January 30, 2023
Estimating tissue-specific peptide abundance from public RNA-Seq dataAngela Frentzen, Jason A Greenbaum, Haeuk Kim, et al.
Oncoimmunology|November 1, 2018
Predicting T cell recognition of MHC class I restricted neoepitopesZeynep Koşaloğlu-Yalçın, Manasa Lanka, Angela Frentzen, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2025
A meta-analysis of experimentally validated neo-epitopes: patterns, biases, and opportunitiesAlessandro Sette, Ibel Carri, Daniel Marrama, et al.
Science Translational Medicine|February 28, 2024
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancerAaron M Miller, Zeynep Koşaloğlu-Yalçın, Luise Westernberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Genetics|January 30, 2023
Estimating tissue-specific peptide abundance from public RNA-Seq dataAngela Frentzen, Jason A Greenbaum, Haeuk Kim, et al.
Oncoimmunology|November 1, 2018
Predicting T cell recognition of MHC class I restricted neoepitopesZeynep Koşaloğlu-Yalçın, Manasa Lanka, Angela Frentzen, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2025
A meta-analysis of experimentally validated neo-epitopes: patterns, biases, and opportunitiesAlessandro Sette, Ibel Carri, Daniel Marrama, et al.
Science Translational Medicine|February 28, 2024
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancerAaron M Miller, Zeynep Koşaloğlu-Yalçın, Luise Westernberg, et al.
Pageof 1